80 related articles for article (PubMed ID: 6794630)
1. Reduced immunoregulatory potency of low density lipoproteins with selectively modified arginine and lysine residues of apolipoprotein B.
Noel JG; Hui DY; Blankenship DT; Harmony JA
Biochim Biophys Acta; 1981 Sep; 665(3):519-30. PubMed ID: 6794630
[TBL] [Abstract][Full Text] [Related]
2. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.
Weisgraber KH; Innerarity TL; Mahley RW
J Biol Chem; 1978 Dec; 253(24):9053-62. PubMed ID: 214439
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys.
Mahley RW; Weisgraber KH; Melchior GW; Innerarity TL; Holcombe KS
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):225-9. PubMed ID: 6767236
[TBL] [Abstract][Full Text] [Related]
4. Binding of plasma low density lipoproteins to erythrocytes.
Hui DY; Noel JG; Harmony JA
Biochim Biophys Acta; 1981 Jun; 664(3):513-26. PubMed ID: 6791697
[TBL] [Abstract][Full Text] [Related]
5. In vivo characteristics of a specific recognition site for LDL on non-parenchymal rat liver cells which differs from the 17 alpha-ethinyl estradiol-induced LDL receptor on parenchymal liver cells.
Harkes L; Van Berkel TJ
Biochim Biophys Acta; 1984 Jul; 794(2):340-7. PubMed ID: 6329312
[TBL] [Abstract][Full Text] [Related]
6. Lysine and arginine residues in the N-terminal 18% of apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein.
Bakillah A; Jamil H; Hussain MM
Biochemistry; 1998 Mar; 37(11):3727-34. PubMed ID: 9521691
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products.
Steinbrecher UP
J Biol Chem; 1987 Mar; 262(8):3603-8. PubMed ID: 3102491
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages.
Zhang H; Yang Y; Steinbrecher UP
J Biol Chem; 1993 Mar; 268(8):5535-42. PubMed ID: 8383674
[TBL] [Abstract][Full Text] [Related]
9. A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor.
Lund-Katz S; Ibdah JA; Letizia JY; Thomas MT; Phillips MC
J Biol Chem; 1988 Sep; 263(27):13831-8. PubMed ID: 3138240
[TBL] [Abstract][Full Text] [Related]
10. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
Dashti N; Wolfbauer G
Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B.
Hui DY; Harmony JA; Innerarity TL; Mahley RW
J Biol Chem; 1980 Dec; 255(24):11775-81. PubMed ID: 7440569
[TBL] [Abstract][Full Text] [Related]
12. Accelerated clearance of low-density and high-density lipoproteins and retarded clearance of E apoprotein-containing lipoproteins from the plasma of rats after modification of lysine residues.
Mahley RW; Weisgraber KH; Innerarity TL; Windmueller HG
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1746-50. PubMed ID: 221905
[TBL] [Abstract][Full Text] [Related]
13. The biochemistry of epsilon-amino groups of lysine residues from apolipoprotein B of human low density lipoprotein.
Cocuzzi E; Breckenridge WC
Atherosclerosis; 1986 Jul; 61(1):25-34. PubMed ID: 3730052
[TBL] [Abstract][Full Text] [Related]
14. The secondary structure of apolipoproteins in human HDL3 particles after chemical modification of their tyrosine, lysine, cysteine or arginine residues. A Fourier transform infrared spectroscopy study.
Herzyk E; Owen JS; Chapman D
Biochim Biophys Acta; 1988 Sep; 962(1):131-42. PubMed ID: 2843239
[TBL] [Abstract][Full Text] [Related]
15. Low density lipoprotein derivatization by acetaldehyde affects lysine residues and the B/E receptor binding affinity.
Kervinen K; Savolainen MJ; Tikkanen MJ; Kesäniemi YA
Alcohol Clin Exp Res; 1991 Dec; 15(6):1050-5. PubMed ID: 1789380
[TBL] [Abstract][Full Text] [Related]
16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
17. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.
Haberland ME; Fogelman AM; Edwards PA
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):1712-6. PubMed ID: 6281781
[TBL] [Abstract][Full Text] [Related]
18. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins.
Mahley RW; Innerarity TL; Weisgraber KB; Oh SY
J Clin Invest; 1979 Sep; 64(3):743-50. PubMed ID: 224077
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by membrane-bound low-density lipoproteins of the primary inductive events of mitogen-stimulated lymphocyte activation.
Harmony JA; Hui DY
Cancer Res; 1981 Sep; 41(9 Pt 2):3799-802. PubMed ID: 6266668
[TBL] [Abstract][Full Text] [Related]
20. Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.
Curtiss LK; Edgington TS
J Clin Invest; 1978 May; 61(5):1298-308. PubMed ID: 207735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
